IndraLab

Statements


USP10 activates xenograft growth. 2 / 2
| 2

eidos
"Depletion or inhibition of USP10 reduces xenograft growth and sensitizes xenografts to cisplatin The data presented up to this point prompted us to test whether depletion of USP10 in cancers lacking wild-type p53 decreases tumorigenesis and increases chemosensitivity in vivo ."

eidos
"Knockdown of USP10 drastically reduced xenograft growth , and in combination with cisplatin treatment almost completely abolished tumor initiation ."